As of April 2024 Amphastar Pharmaceuticals has a market cap of $1.99 Billion. This makes Amphastar Pharmaceuticals the world's 4073th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.99 B | -32.53% |
2023 | $2.96 B | 118.8% |
2022 | $1.35 B | 21.52% |
2021 | $1.11 B | 16.68% |
2020 | $0.95 B | 6.31% |
2019 | $0.89 B | -3.18% |
2018 | $0.92 B | 4.9% |
2017 | $0.88 B | 4.34% |
2016 | $0.84 B | 31.81% |
2015 | $0.64 B | 24.08% |
2014 | $0.51 B |
On Apr 23rd, 2024 the market cap of Amphastar Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Tonix Pharmaceuticals TNXP | $14.98 M | -99.25% | ๐บ๐ธ USA |
SCYNEXIS SCYX | $58.51 M | -97.07% | ๐บ๐ธ USA |
Marinus Pharmaceuticals MRNS | $79.1 M | -96.04% | ๐บ๐ธ USA |
Agile Therapeutics
AGRX | $2.53 M | -99.87% | ๐บ๐ธ USA |